| 000 | 01815 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515053125.0 | ||
| 264 | 0 | _c20070329 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a0022-2828 | ||
| 024 | 7 |
_a10.1016/j.yjmcc.2006.11.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIsabelle, Marc | |
| 245 | 0 | 0 |
_aNADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction. _h[electronic resource] |
| 260 |
_bJournal of molecular and cellular cardiology _cFeb 2007 |
||
| 300 |
_a326-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetophenones _xpharmacology |
| 650 | 0 | 4 |
_aAllopurinol _xpharmacology |
| 650 | 0 | 4 |
_aAnesthetics, Local _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiomyopathies _xchemically induced |
| 650 | 0 | 4 |
_aCocaine _xtoxicity |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardium _xenzymology |
| 650 | 0 | 4 |
_aNADPH Oxidases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aVentricular Dysfunction, Left _xchemically induced |
| 650 | 0 | 4 |
_aXanthine Dehydrogenase _xbiosynthesis |
| 700 | 1 | _aVergeade, Aurélia | |
| 700 | 1 | _aMoritz, Fabienne | |
| 700 | 1 | _aDautréaux, Brigitte | |
| 700 | 1 | _aHenry, Jean-Paul | |
| 700 | 1 | _aLallemand, Françoise | |
| 700 | 1 | _aRichard, Vincent | |
| 700 | 1 | _aMulder, Paul | |
| 700 | 1 | _aThuillez, Christian | |
| 700 | 1 | _aMonteil, Christelle | |
| 773 | 0 |
_tJournal of molecular and cellular cardiology _gvol. 42 _gno. 2 _gp. 326-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.yjmcc.2006.11.011 _zAvailable from publisher's website |
| 999 |
_c16783342 _d16783342 |
||